Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
《大行》匯豐研究升醫脈通目標價至13.5元 評級降至「持有」

2025-03-26T  
《業績》醫脈通全年純利3.15億人民幣增30% 末期息派13.66分

2025-03-24T  
《大行》里昂:中國互聯網醫療保健行業乘著AI浪潮

2025-02-17T  
《業績》醫脈通半年純利1.47億元人民幣升48.6% 中期息12.05分人民幣

2024-08-27T  
醫脈通與NCCN達成癌症護理戰略合作

2024-07-30T  
《公司業績》醫脈通全年純利2.42億人民幣增107% 末期息派12.48分

2024-03-25T  
《盈利預喜》醫脈通料去年純利增長一倍

2024-02-28T  
醫療平台股普遍隨大市造好 阿里健康及平安好醫生升6%-7%

2024-02-16T  
《異動股》藥師幫股價回升17.5%成交增

2023-11-27T  
阿里健康午後曾挫逾9% 惟醫脈通及藥師幫逆市續升2%-4%

2023-11-17T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.